Speaker Profile

J.D., Vice President- Business Development, Karius Inc.

Biography
Mr. Kortschak has over 25 years experience developing and commercializing clinical diagnostic products across multiple technologies. His recent focus is supporting biomarker identification and biopharma support at Karius utilizing the non-invasive, liquid biopsy technology to detect mcfDNA in plasma.


Microbial Profiling Showcase:
Karius, Inc.

Karius utilizes an innovative liquid biopsy assay to identify over 1600 pathogens in plasma.

Microbial Profiling in Precision Medicine
The Karius test is used to discover new microbial biomarkers and develop assays that can help select patients, predict response, enable early detection, and monitor disease progression and remission.

 Session Abstract – PMWC 2022 Silicon Valley


The PMWC 2022 Microbial Profiling Showcase will provide a 15-minute time slot for selected companies in the Microbiome and Pathogen ID fields. The human microbiome is composed of a wide variety of microorganisms that are essential for maintaining human health and preventing disease. Research in this area is accelerating due to the rapid development in genome sequencing technologies. This showcase will present some of the leading companies in microbial profiling and pathogen identification.